Ginkgo Bioworks Hldgs Inc (DNA)

$13.57 +0.36 (2.73%)
Market Cap 782.03M
Revenue (ttm) 227.04M
Net Income (ttm) -547.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -240.94%
Debt to Equity Ratio 0.00
Volume 1,170,400
Avg Vol 1,648,466
Day's Range N/A - N/A
Shares Out 59.20M
Stochastic %K 34%
Beta 1.54
Analysts Hold
Price Target $12.00

Company Profile

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, developm...

Industry: Biotechnology
Sector: Healthcare
Phone: 877 422 5362
Address:
27 Drydock Avenue, 8th Floor, Boston, United States
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 9:18 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $DNA Current Share Price: $13.57 Contracts: $DNA January 15, 2027 $15 Calls Scale in: $4.90- $6.00 Scale out: $7.63-$9.81 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com
0 · Reply
invinc1ble
invinc1ble Oct. 25 at 3:14 PM
$DNA 20 🎯
0 · Reply
Yyzcan
Yyzcan Oct. 24 at 6:58 PM
$DNA @TheHowlingMadness The put experts come back with never expired put 😂, just keep the same tone to get more innocent followers in here.
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 24 at 6:48 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $DNA Current Share Price: $13.22 Contracts: $DNA January 15, 2027 $15 Calls Scale in: $4.70- $5.75 Scale out: $7.31-$9.40 Can Easily Capture: 60% ROI Blended DTE: 449 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
BillionerOfKing
BillionerOfKing Oct. 23 at 2:35 PM
$DNA Current Stock Price: $13.14 Contracts to trade: $15 DNA Nov 21 2025 Call Entry: $0.90 Exit: $1.74 ROI: 93% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 23 at 9:30 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $DNA Current Share Price: $12.78 Contracts: $DNA January 15, 2027 $15 Calls Scale in: $4.66- $5.69 Scale out: $7.24-$9.31 Can Easily Capture: 60% ROI Blended DTE: 450 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
TheHowlingMadness
TheHowlingMadness Oct. 23 at 4:18 AM
$DNA under 10 eow. 🤌
2 · Reply
Sf249
Sf249 Oct. 21 at 3:48 PM
$TELO ugh added more loaded for a repeat of last nights after market run $EDIT , $NTLA $DNA
1 · Reply
Yaniv1235
Yaniv1235 Oct. 21 at 1:52 PM
$DNA
1 · Reply
Shaffin786
Shaffin786 Oct. 21 at 1:38 AM
$DNA Ginkgo Bioworks serves as a real-world exemplar of the shift the article describes from reading to writing life’s code. It illustrates the “platform” side of synthetic biology: enabling the design and engineering of organisms, treating DNA as code, and building the tools to make large-scale genome writing and organism engineering possible.
0 · Reply
Latest News on DNA
Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program

Oct 23, 2025, 8:00 AM EDT - 2 days ago

Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program

Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium

Sep 4, 2025, 8:00 AM EDT - 7 weeks ago

Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium

Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions

Aug 29, 2025, 4:05 PM EDT - 2 months ago

Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry

Aug 20, 2025, 8:01 AM EDT - 2 months ago

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry

Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth

Aug 12, 2025, 8:01 AM EDT - 2 months ago

Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth

Ginkgo Bioworks: Sell The Recent Rally

Aug 11, 2025, 5:51 AM EDT - 2 months ago

Ginkgo Bioworks: Sell The Recent Rally

Ginkgo Bioworks Holdings, Inc. (DNA) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 3:16 AM EDT - 2 months ago

Ginkgo Bioworks Holdings, Inc. (DNA) Q2 2025 Earnings Call Transcript

Ginkgo Bioworks Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 5:01 PM EDT - 2 months ago

Ginkgo Bioworks Reports Second Quarter 2025 Financial Results

Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation

Jul 31, 2025, 8:01 AM EDT - 3 months ago

Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation

Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy

Jul 30, 2025, 9:01 AM EDT - 3 months ago

Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy

Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors

Jul 17, 2025, 9:01 AM EDT - 3 months ago

Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors

Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer

May 21, 2025, 4:05 PM EDT - 5 months ago

Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer

Twist Bioscience and Ginkgo Bioworks Revise Collaboration

May 8, 2025, 8:00 AM EDT - 6 months ago

Twist Bioscience and Ginkgo Bioworks Revise Collaboration

TWST

Ginkgo Bioworks Holdings, Inc. (DNA) Q1 2025 Earnings Call Transcript

May 6, 2025, 9:19 PM EDT - 6 months ago

Ginkgo Bioworks Holdings, Inc. (DNA) Q1 2025 Earnings Call Transcript

Ginkgo Bioworks Reports First Quarter 2025 Financial Results

May 6, 2025, 5:00 PM EDT - 6 months ago

Ginkgo Bioworks Reports First Quarter 2025 Financial Results

Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors

Apr 30, 2025, 9:00 AM EDT - 6 months ago

Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors

Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation

Apr 29, 2025, 4:00 PM EDT - 6 months ago

Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation

Ginko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation

Apr 22, 2025, 9:00 AM EDT - 6 months ago

Ginko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation

Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain

Apr 10, 2025, 9:00 AM EDT - 7 months ago

Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain

DCI

Plex Research Partners With Ginkgo Bioworks on Artificial Intelligence (AI)-Powered Drug Discovery to Identify Novel Disease Mechanisms and Pathways

Apr 3, 2025, 9:01 AM EDT - 7 months ago

Plex Research Partners With Ginkgo Bioworks on Artificial Intelligence (AI)-Powered Drug Discovery to Identify Novel Disease Mechanisms and Pathways

Ginkgo Bioworks: Revenue Struggles Continue

Feb 27, 2025, 10:29 AM EST - 8 months ago

Ginkgo Bioworks: Revenue Struggles Continue

2025 Is Make Or Break For Ginkgo Bioworks

Feb 27, 2025, 6:19 AM EST - 8 months ago

2025 Is Make Or Break For Ginkgo Bioworks

Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Feb 26, 2025, 8:10 AM EST - 8 months ago

Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

FLYW

Ginkgo Bioworks Holdings, Inc. (DNA) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 9:22 PM EST - 8 months ago

Ginkgo Bioworks Holdings, Inc. (DNA) Q4 2024 Earnings Call Transcript

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 25, 2025, 5:00 PM EST - 8 months ago

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results

Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab

Feb 21, 2025, 9:00 AM EST - 8 months ago

Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care

Feb 20, 2025, 8:01 AM EST - 8 months ago

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation

Feb 18, 2025, 8:00 AM EST - 8 months ago

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation

Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series

Feb 6, 2025, 8:01 AM EST - 9 months ago

Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series

Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC)

Jan 23, 2025, 8:01 AM EST - 9 months ago

Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC)

SaponiQx, Probius, and Ginkgo Bioworks Unite to Revolutionize Vaccine Adjuvant Development

Jan 21, 2025, 7:00 AM EST - 9 months ago

SaponiQx, Probius, and Ginkgo Bioworks Unite to Revolutionize Vaccine Adjuvant Development

Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors

Jan 13, 2025, 8:01 AM EST - 10 months ago

Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors

Rapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma and Genomics

Jan 9, 2025, 11:38 AM EST - 10 months ago

Rapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma and Genomics

Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Jan 9, 2025, 8:00 AM EST - 10 months ago

Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program

Dec 17, 2024, 8:11 AM EST - 11 months ago

Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program

Ginkgo Bioworks: Unproven Transition But 2025 Is Looking Better

Nov 18, 2024, 10:36 AM EST - 1 year ago

Ginkgo Bioworks: Unproven Transition But 2025 Is Looking Better

Ginkgo Bioworks: Not Enough Progress

Nov 13, 2024, 8:36 AM EST - 1 year ago

Ginkgo Bioworks: Not Enough Progress

Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 10:02 PM EST - 1 year ago

Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2024 Earnings Call Transcript

Ginkgo Bioworks Reports Third Quarter 2024 Financial Results

Nov 12, 2024, 5:01 PM EST - 1 year ago

Ginkgo Bioworks Reports Third Quarter 2024 Financial Results

Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing

Nov 12, 2024, 8:01 AM EST - 1 year ago

Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing

Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation

Nov 5, 2024, 7:00 AM EST - 1 year ago

Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation

Ginkgo Bioworks (DNA) Shares Drop Amid Weak Earnings and Sell Ratings

Oct 9, 2024, 3:39 PM EDT - 1 year ago

Ginkgo Bioworks (DNA) Shares Drop Amid Weak Earnings and Sell Ratings

Virica Biotech and Ginkgo Bioworks Announce Partnership to Accelerate AAV Gene Therapy Manufacturing

Oct 3, 2024, 7:03 AM EDT - 1 year ago

Virica Biotech and Ginkgo Bioworks Announce Partnership to Accelerate AAV Gene Therapy Manufacturing

NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture

Sep 24, 2024, 7:01 AM EDT - 1 year ago

NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture

Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology

Sep 18, 2024, 7:01 AM EDT - 1 year ago

Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology

Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology

Sep 17, 2024, 8:01 AM EDT - 1 year ago

Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology

Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement

Sep 4, 2024, 4:30 PM EDT - 1 year ago

Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement

NYSE to Commence Delisting Proceedings with Respect to the Warrants of Ginkgo Bioworks Holdings, Inc. (DNA.WS)

Sep 4, 2024, 4:05 PM EDT - 1 year ago

NYSE to Commence Delisting Proceedings with Respect to the Warrants of Ginkgo Bioworks Holdings, Inc. (DNA.WS)

Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 30, 2024, 7:00 AM EDT - 1 year ago

Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference

From Promise to Peril: The Downfall of Ginkgo Bioworks

Aug 26, 2024, 11:51 AM EDT - 1 year ago

From Promise to Peril: The Downfall of Ginkgo Bioworks

LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 9:18 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $DNA Current Share Price: $13.57 Contracts: $DNA January 15, 2027 $15 Calls Scale in: $4.90- $6.00 Scale out: $7.63-$9.81 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com
0 · Reply
invinc1ble
invinc1ble Oct. 25 at 3:14 PM
$DNA 20 🎯
0 · Reply
Yyzcan
Yyzcan Oct. 24 at 6:58 PM
$DNA @TheHowlingMadness The put experts come back with never expired put 😂, just keep the same tone to get more innocent followers in here.
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 24 at 6:48 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $DNA Current Share Price: $13.22 Contracts: $DNA January 15, 2027 $15 Calls Scale in: $4.70- $5.75 Scale out: $7.31-$9.40 Can Easily Capture: 60% ROI Blended DTE: 449 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
BillionerOfKing
BillionerOfKing Oct. 23 at 2:35 PM
$DNA Current Stock Price: $13.14 Contracts to trade: $15 DNA Nov 21 2025 Call Entry: $0.90 Exit: $1.74 ROI: 93% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 23 at 9:30 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $DNA Current Share Price: $12.78 Contracts: $DNA January 15, 2027 $15 Calls Scale in: $4.66- $5.69 Scale out: $7.24-$9.31 Can Easily Capture: 60% ROI Blended DTE: 450 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
TheHowlingMadness
TheHowlingMadness Oct. 23 at 4:18 AM
$DNA under 10 eow. 🤌
2 · Reply
Sf249
Sf249 Oct. 21 at 3:48 PM
$TELO ugh added more loaded for a repeat of last nights after market run $EDIT , $NTLA $DNA
1 · Reply
Yaniv1235
Yaniv1235 Oct. 21 at 1:52 PM
$DNA
1 · Reply
Shaffin786
Shaffin786 Oct. 21 at 1:38 AM
$DNA Ginkgo Bioworks serves as a real-world exemplar of the shift the article describes from reading to writing life’s code. It illustrates the “platform” side of synthetic biology: enabling the design and engineering of organisms, treating DNA as code, and building the tools to make large-scale genome writing and organism engineering possible.
0 · Reply
VossNorway
VossNorway Oct. 20 at 9:47 PM
$DNA The next revolution in biology isn’t reading life’s code — it’s writing it https://bigthink.com/life/the-next-revolution-in-biology-isnt-reading-lifes-code-its-writing-it/
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 20 at 5:03 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $DNA Current Share Price: $13.25 Contracts: $DNA January 15, 2027 $15 Calls Scale in: $5.26- $6.44 Scale out: $8.19-$10.53 Can Easily Capture: 60% ROI Blended DTE: 453 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
FairValTrading
FairValTrading Oct. 19 at 1:21 AM
$DNA $XBI $IBB $ARK.X
0 · Reply
jaydilks
jaydilks Oct. 18 at 11:24 AM
$DNA It would go a long way if Jason Kelly would put out a video that explained progress on every announcement of the last 5 years that still was progressing . I always assume that it will take 18-24 months for anything announced in previous years. Even saying what failed would give tremendous transparency that’s greatly needed at the moment. If no video, just push out a chart that has checkmarks of three levels of progress starting with Development and ending in Commercialization. There are so many older investors that want to throw money at this but genuinely have no idea what they are investing in any longer. I understand partners want to remain silent on progress but an opaque window has turned into a Black Curtain.
2 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 17 at 7:51 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $DNA Current Share Price: $15.12 Contracts: $DNA January 15, 2027 $17 Calls Scale in: $5.22- $6.38 Scale out: $8.12-$10.44 Can Easily Capture: 60% ROI Blended DTE: 455 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
CameoBrien
CameoBrien Oct. 17 at 5:12 PM
$DNA 👀
0 · Reply
Yaniv1235
Yaniv1235 Oct. 17 at 2:46 PM
$DNA perfect price
0 · Reply
Gautengtrader
Gautengtrader Oct. 17 at 1:26 AM
$DNA thank god I bailed @16.08
1 · Reply
Gautengtrader
Gautengtrader Oct. 16 at 6:08 PM
$DNA I had to dump 1250 shares
0 · Reply
Nalviation
Nalviation Oct. 16 at 5:30 PM
$DNA 400 price target IPO price 2026 😋💥🚀🤑🔥
2 · Reply
Yyzcan
Yyzcan Oct. 16 at 2:18 PM
$DNA He even had no idea what's the Put expired date, and just all the way down and try his luck to get innocent followers. If you check his comments in other stocks, the rate of win is less than 30%, No worth to care his points at all.
1 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 16 at 1:27 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $DNA Current Share Price: $15.83 Contracts: $DNA January 15, 2027 $17 Calls Scale in: $5.47- $6.68 Scale out: $8.50-$10.93 Can Easily Capture: 60% ROI Blended DTE: 456 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply